Literature DB >> 9385038

Cerebral amyloid angiopathy in the elderly: the clinicopathological features, pathogenesis, and risk factors.

Y Itoh1, M Yamada.   

Abstract

Cerebral amyloid angiopathy (CAA) is known to be associated with intracerebral hemorrhage in the elderly. In this study we demonstrated that, among 101 cases with intracerebral hemorrhages found in 1000 consecutive autopsied cases (average age, 82.9 years) at a geriatric hospital, CAA accounted for 10.9% of them (31.0% of lobar and 14.3% of cerebellar hemorrhages). Immunohistochemically, the cerebrovascular amyloid was positive for beta/A4 peptide, and less intensely for cystatin C. The CAA-related hemorrhages were characteristically located near the cortical surface and ruptured into the subarachnoid space. No mutation of the amyloid precursor protein gene or the cystatin C gene was detected in these cases. From the observation of 500 serial sections containing amyloid-laden vessels of a patient with CAA-related hemorrhage, it was suggested that the hemorrhage occurred at microaneurysms with fibrinoid necrosis, which were found in small arteries in the cerebral cortex. The spatial distribution of CAA was closely associated with that of subpial beta/A4 peptide deposits in the brain, raising the possibility that the cerebrovascular amyloid originates from the brain parenchyma. Finally, the severity of CAA did not seem to be influenced by the inheritance of the epsilon 4 allele of the apolipoprotein E gene, which is known as a risk factor for dementia of the Alzheimer type.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385038

Source DB:  PubMed          Journal:  J Med Dent Sci        ISSN: 1342-8810


  8 in total

1.  The incidence of cerebral amyloid angiopathy in surgically treated intracranial hemorrhage in the Chinese population.

Authors:  Ya-juan Tang; Yong Li; Shuo Wang; Ming-wei Zhu; Yi-lin Sun; Ji-zong Zhao
Journal:  Neurosurg Rev       Date:  2013-06-14       Impact factor: 3.042

2.  Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.

Authors:  Byung Hee Han; Meng-Liang Zhou; Andrew W Johnson; Itender Singh; Fan Liao; Ananth K Vellimana; James W Nelson; Eric Milner; John R Cirrito; Jacob Basak; Min Yoo; Hans H Dietrich; David M Holtzman; Gregory Joseph Zipfel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

3.  Study of clinical features of amyloid angiopathy hemorrhage and hypertensive intracerebral hemorrhage.

Authors:  Ren-ya Zhan; Ying Tong; Jian-feng Shen; E Lang; C Preul; R G Hempelmann; H H Hugo; R Buhl; H Barth; H Klinge; H M Mehdorn
Journal:  J Zhejiang Univ Sci       Date:  2004-10

Review 4.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

5.  Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy.

Authors:  Byung Hee Han; Meng-liang Zhou; Ananth K Vellimana; Eric Milner; David H Kim; Jacob K Greenberg; Wenhua Chu; Robert H Mach; Gregory J Zipfel
Journal:  Mol Neurodegener       Date:  2011-12-22       Impact factor: 14.195

6.  Clinical Neuropathological Analysis of 10 Cases of Cerebral Amyloid Angiopathy-Related Cerebral Lobar Hemorrhage.

Authors:  Xiao-Qiu Li; Dong-Feng Su; Hui-Sheng Chen; Qu Fang
Journal:  J Korean Neurosurg Soc       Date:  2015-07-31

7.  Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy.

Authors:  Susanne J van Veluw; Hugo J Kuijf; Andreas Charidimou; Anand Viswanathan; Geert Jan Biessels; Annemieke J M Rozemuller; Matthew P Frosch; Steven M Greenberg
Journal:  Acta Neuropathol       Date:  2016-10-22       Impact factor: 17.088

Review 8.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.